2. Academic Validation
  3. Yueju pill and its active component- Myricetin attenuate the reinstatement of methamphetamine-seeking behavior in mice

Yueju pill and its active component- Myricetin attenuate the reinstatement of methamphetamine-seeking behavior in mice

  • Int Immunopharmacol. 2025 Sep 26:166:115601. doi: 10.1016/j.intimp.2025.115601.
Yanfeng Du 1,  Shuyuan Fan 1,  Xialin Yang 2,  Wei Ma 1,  Shiqi Li 1,  Yixin Xu 1,  Cui Li 2,  Shuman Chen 2,  Yueyuan Wang 2,  Meifang Wang 3,  Tengfei Ma 4,  Junlong Zhang 5
Affiliations

Affiliations

  • 1 Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
  • 2 Department of Anesthesiology, Lianyungang Clinical College of Xuzhou Medical University, the Second People's Hospital of Lianyungang, Lianyungang 222000, Jiangsu, China.
  • 3 Department of Anesthesiology, the Affiliated Changshu Second People's Hospital of Nantong University, Changshu 215500, China. Electronic address: 2003wmf@163.com.
  • 4 Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China; Jiangsu Province Innovation center for Brain-Inspired intelligence technology, Nanjing Medical University, Nanjing 211166, China. Electronic address: tfma@njmu.edu.cn.
  • 5 Department of Anesthesiology, Lianyungang Clinical College of Xuzhou Medical University, the Second People's Hospital of Lianyungang, Lianyungang 222000, Jiangsu, China. Electronic address: zjlddqzyw@126.com.
PMID: 41014771 DOI: 10.1016/j.intimp.2025.115601
Abstract

Yueju pill (YJ), a traditional Chinese medicine, is widely used for the treatment of depression and pain due to its ability to prevent neuroinflammatory responses, regulate synaptic plasticity, and enhance cognitive function. Methamphetamine (METH) addiction is a chronic brain disease associated with inflammation and aberrant synaptic plasticity. However, whether and how YJ with its active components attenuates the METH-induced behavior remain unclear. In this study, we demonstrated that YJ attenuated the reinstatement of METH-seeking behavior while decreasing the activity of hippocampal CA1 neurons. Furthermore, YJ prevented METH-induced aberrant potentiation of glutamatergic transmission and restored physiological synaptic plasticity, likely mediated by upregulated expression of brain-derived neurotrophic factor (BDNF) and postsynaptic density protein 95 (PSD95). Importantly, hippocampal CA1-specific knockdown of BDNF abolished the protective effects of YJ on METH-seeking behavior and synaptic dysfunction, confirming BDNF's pivotal role in YJ's mechanism of action. Mechanistically, YJ exerts its therapeutic effects by suppressing NLRP3 inflammasome activation. Notably, pharmacological activation of NLRP3 counteracted YJ-induced BDNF upregulation, suggesting that YJ restores synaptic plasticity, at least in part, through NLRP3 inhibition and subsequent microglial inactivation. Among its bioactive constituents, myricetin was identified as a key component responsible for reducing METH-seeking behavior and inflammatory responses. Collectively, our findings reveal that YJ attenuates aberrant synaptic plasticity by downregulating the NLRP3 inflammasome and enhancing BDNF expression in the hippocampus. These insights highlight the potential of targeting neuroimmune pathways and synaptic plasticity to develop novel therapeutic strategies for METH addiction.

Keywords

Hippocampus; Methamphetamine; NLRP3 inflammasome; Synaptic plasticity; Yueju pill.

Figures
Products